“Pharmacological Evaluation of CB2 Receptor Modulator in the Treatment of Neuropathic Pain”. 2025. Journal of Carcinogenesis 24 (2s): 867-85. https://doi.org/10.64149/J.Carcinog.24.2s.867-885.